BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 355,055 Value ($000) $2,574 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 309,110 Value ($000) $2,346 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 99,046 Value ($000) $887 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 101,378 Value ($000) $760 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 101,188 Value ($000) $761 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 86,533 Value ($000) $658 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 97,577 Value ($000) $603 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 89,614 Value ($000) $455 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 53,330 Value ($000) $319 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 33,128 Value ($000) $235 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 32,622 Value ($000) $230 Avg Close $8.02 Range $6.87 - $9.07
Q3 2022
Shares 14,285 Value ($000) $180 Avg Close $12.87 Range $10.33 - $15.43
Q1 2021
Shares 30,950 Value ($000) $315 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 178,325 Value ($000) $1,329 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 129,470 Value ($000) $445 Avg Close $4.29 Range $3.30 - $6.03
Q2 2020
Shares 82,955 Value ($000) $395 Avg Close $3.99 Range $1.80 - $6.29
Q1 2020
Shares 119,180 Value ($000) $238 Avg Close $2.75 Range $1.58 - $4.35
Q4 2019
Shares 89,050 Value ($000) $307 Avg Close $2.52 Range $1.38 - $3.48
Q3 2017
Shares 25,170 Value ($000) $132 Avg Close $5.12 Range $3.95 - $6.22
Q1 2015
Shares 12,860 Value ($000) $116 Avg Close $10.35 Range $7.85 - $12.71